Araujo Gustavo N, Pivatto Junior Fernando, Fuhr Bruno, Cassol Elvis P, Machado Guilherme P, Valle Felipe H, Bergoli Luiz C, Wainstein Rodrigo V, Polanczyk Carisi A, Wainstein Marco V
Cardiology Service, Hospital de Clinicas de Porto Alegre, Ramiro Barcelos 2350, Porto Alegre, RS, 90035-003, Brazil.
School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Cardiovasc Interv Ther. 2018 Jul;33(3):224-231. doi: 10.1007/s12928-017-0472-y. Epub 2017 May 24.
Contrast-induced acute kidney injury (CI-AKI) is a common event after percutaneous coronary intervention (PCI). Presently, the main strategy to avoid CI-AKI lies in saline hydration, since to date none pharmacologic prophylaxis proved beneficial. Our aim was to determine if a low complexity mortality risk model is able to predict CI-AKI in patients undergoing PCI after ST elevation myocardial infarction (STEMI). We have included patients with STEMI submitted to primary PCI in a tertiary hospital. The definition of CI-AKI was a raise of 0.3 mg/dL or 50% in post procedure (24-72 h) serum creatinine compared to baseline. Age, glomerular filtration and ejection fraction were used to calculate ACEF-MDRD score. We have included 347 patients with mean age of 60 years. In univariate analysis, age, diabetes, previous ASA use, Killip 3 or 4 at admission, ACEF-MDRD and Mehran scores were predictors of CI-AKI. After multivariate adjustment, only ACEF-MDRD score and diabetes remained CI-AKI predictors. Areas under the ROC curve of ACEF-MDRD and Mehran scores were 0.733 (0.68-0.78) and 0.649 (0.59-0.70), respectively. When we compared both scores with DeLong test ACEF-MDRDs AUC was greater than Mehran's (P = 0.03). An ACEF-MDRD score of 2.33 or lower has a negative predictive value of 92.6% for development of CI-AKI. ACEF-MDRD score is a user-friendly tool that has an excellent CI-AKI predictive accuracy in patients undergoing primary percutaneous coronary intervention. Moreover, a low ACEF-MDRD score has a very good negative predictive value for CI-AKI, which makes this complication unlikely in patients with an ACEF-MDRD score of <2.33.
造影剂诱导的急性肾损伤(CI-AKI)是经皮冠状动脉介入治疗(PCI)后常见的情况。目前,避免CI-AKI的主要策略在于生理盐水水化,因为迄今为止尚无药物预防措施被证明有益。我们的目的是确定一个低复杂度的死亡风险模型是否能够预测ST段抬高型心肌梗死(STEMI)后接受PCI治疗的患者发生CI-AKI的情况。我们纳入了一家三级医院中接受直接PCI治疗的STEMI患者。CI-AKI的定义为术后(24 - 72小时)血清肌酐较基线升高0.3mg/dL或升高50%。年龄、肾小球滤过率和射血分数用于计算ACEF-MDRD评分。我们纳入了347例平均年龄为60岁的患者。单因素分析中,年龄、糖尿病、既往使用阿司匹林、入院时Killip 3或4级、ACEF-MDRD和梅兰评分是CI-AKI的预测因素。多因素调整后,只有ACEF-MDRD评分和糖尿病仍是CI-AKI的预测因素。ACEF-MDRD评分和梅兰评分的ROC曲线下面积分别为0.733(0.68 - 0.78)和0.649(0.59 - 0.70)。当我们用德龙检验比较这两个评分时,ACEF-MDRD的AUC大于梅兰评分(P = 0.03)。ACEF-MDRD评分为2.33或更低时,对CI-AKI发生的阴性预测值为92.6%。ACEF-MDRD评分是一种用户友好的工具,在接受直接经皮冠状动脉介入治疗的患者中对CI-AKI具有出色的预测准确性。此外,低ACEF-MDRD评分对CI-AKI具有非常好的阴性预测价值,这使得ACEF-MDRD评分<2.33的患者不太可能发生这种并发症。